Form 8-K - Current report:
SEC Accession No. 0001561743-21-000014
Filing Date
2021-02-09
Accepted
2021-02-09 09:08:40
Documents
15
Period of Report
2021-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kin-20210205.htm   iXBRL 8-K 43367
2 EX-99.1 pr_kindredbioboardappointm.htm EX-99.1 8233
  Complete submission text file 0001561743-21-000014.txt   243958

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20210205.xsd EX-101.SCH 2565
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20210205_cal.xml EX-101.CAL 713
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20210205_def.xml EX-101.DEF 16701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20210205_lab.xml EX-101.LAB 30978
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20210205_pre.xml EX-101.PRE 17384
8 EXTRACTED XBRL INSTANCE DOCUMENT kin-20210205_htm.xml XML 14129
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

EIN.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 21604081
SIC: 2834 Pharmaceutical Preparations